Toggle navigation
PDFSEARCH.IO
Document Search Engine - browse more than 18 million documents
Sign up
Sign in
Back to Results
First Page
Meta Content
View Document Preview and Link
October 1, 2015 Regeneron Announces Collaboration with Mitsubishi Tanabe Pharma for Investigational Pain Therapy Fasinumab in Asia NGF Antibody Fasinumab Currently in Phase 2/3 Osteoarthritis Trial Tarrytown, N.Y., Oct.
Add to Reading List
Open Document
File Size: 14,12 KB
Share Result on Facebook
October 1, 2015 Regeneron Announces Collaboration with Mitsubishi Tanabe Pharma for Investigational Pain Therapy Fasinumab in Asia NGF Antibody Fasinumab Currently in Phase 2/3 Osteoarthritis Trial Tarrytown, N.Y., Oct.